<DOC>
	<DOCNO>NCT02858856</DOCNO>
	<brief_summary>This pilot study investigate efficacy safety Deciten granule immunity patient breast carcinoma receive chemotherapy .</brief_summary>
	<brief_title>Clinical Trial Deciten Granule Immunity Breast Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>men woman age 18 year patient histologically cytologically confirm breast tumor patient applicable AC ( doxorubicin + cyclophosphamide ) ECOG score 0 2 patient impossible orally intake patient dementia , delirium depression patient suffer disease like chronic hepatitis B , C hepatocirrhosis severe liver disability ( 3fold normal high range value ALT , AST ) patient diabetes control diet , hypertension , hyperthyroidism , severe systemic disease use investigational product within past 30 day hypersensitivity investigational product others judge appropriate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>